| Property | Value |
|---|
|
?:abstract
|
-
Objective: Determine the seroprevalence and 3 month temporal change of SARS-COV-2 in the US and Puerto Rico in an asymptomatic well population. Results: The prevalence of SARS-CoV-2 in the asymptomatic population has doubled during the May to September time period, going from 3.0% to 6.6%. Positive serology to SARS-COV-2 was similar in males and females but varies by age. The greatest increase was in the youngest population. Based on the September prevalence it is estimated that there are 11.1 million (bootstrap 95% CI: 10.8 - 11.5 million) asymptomatic SARS-CoV-2 infections in the US, which is 1.95 times the cumulative number of cases in the US reported to the CDC as of September 1, 2020. . Conclusions: The number of new SARS-COV-2 cases more than doubled in this 3 months period. The seroprevalence by age group is high in the youngest (<20, 7.8%) and low in the oldest (> 70, 2.0%). Over the three month study period the rate of increase in prevalence for SARS-COV-2 serology varies by state with a range from 0.84 (State of New York) to more than 12 (Tennessee). This study identifies states were public health mitigation has blunted the spread and also areas where additional levels of intensified public education, surveillance and targeted intervention may be warranted.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1101/2020.11.10.20215145
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/0bd3ea93e0bf778e315a7fae8cee5eaa0784d189.json
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
The Change in Seroprevalence in the US plus Puerto Rico between May and September of SARS-CoV-2 Antibody in the Asymptomatic Population
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}